Kangji Healthcare (09997) opened high and went low in early trading, falling more than 5% in the morning. As of press release, it was down 4.99% to HK$7.05, with a turnover of HK$23.9852 million.
The Zhitong Finance App learned that Kangji Healthcare (09997) opened high and went low in early trading, falling more than 5% in the morning. As of press release, it was down 4.99% to HK$7.05, with a turnover of HK$23.9852 million.
According to the news, Kangji Healthcare announced its annual results for the year ended 2023, with revenue of 926 million yuan, up 17.8% year on year; gross profit of 741 million yuan, up 16.7% year on year; and recorded net profit of 504 million yuan, up 5.3% year on year, with profit of 43.08 points per share. The final interest rate is 41 points; a special interest rate of 99 points is also recommended.
Furthermore, the company announced that according to the revised rules of organization of Weijing Healthcare, the number of directors Kangji Hong Kong is authorized to appoint has been reduced from 4 to 3 of the 7 directors of Weijing Healthcare's board of directors. As a result, Kangji Hong Kong will no longer be able to appoint most of the board members of Weijing Healthcare and will lose control of Weijing Healthcare. The company's reserved interests in Weijing Healthcare will be recorded in the company's consolidated financial statements as an investment in a joint venture company.